Technologies & Devices

C3 Med-Tech

Making Vision Accessible—Smart, Portable, and Affordable Eye Screening for All

C3 Med-Tech offers smartphone-based ophthalmic screening devices designed for early detection of preventable blindness and visual impairment. Our non-invasive, portable solutions deliver diagnostic-quality imaging—matching traditional slit lamps and fundus cameras—using any smartphone. These devices enable screening even in resource-limited settings with minimal training, making them ideal for primary care centers, mobile camps, and remote outreach. Deployed across India, including in government health centers, C3 is on a mission to create a Blind-Free India through scalable, tech-enabled vision care.

Clinically Proven. Innovation-Driven

Captures high-resolution fundus and anterior segment images
C3 devices are approved by US FDA
900+ devices sold across India and abroad.
5400+ eyes screened in rural Gujarat & Odisha in last few months
Showcased at G20 conferences in Hyderabad & Gandhinagar as an ICMR innovation
Reduces need for bulky, expensive ophthalmic equipment
Android-compatible app for real-time image capture, reports, and data sharing

Clinical Collaborators: ICMR, Charitable Institutes, ACT grants & E-Clinics (In Gujarat and Odisha) & Primary & Community Health Centers .

Mentors & Advisors: Leading ophthalmologists across India

Learn more at c3med-tech.com

Dextroware Devices

Mouseware is a hands-free mouse that transforms simple head movements into precise cursor control, enabling seamless access to digital devices without using hands. Designed with cutting-edge motion tracking sensors and customizable settings, Mouseware is lightweight,and compatible with a range of devices and operating systems, including Windows, macOS, and Android, making it adaptable across various platforms. Its versatile design ensures that it can be used with tablets, laptops, desktops, and even smartphones. It empowers users to perform everyday digital tasks like browsing, typing, and designing—all with just head movements. To enhance functionality, Mouseware offers accessories such as a foot switch, a strap-able switch. These accessories add flexibility to the user experience by allowing alternative clicking options, ensuring a comfortable and adaptable solution for users with varying preferences.Whether it's for education, employment, or creative expression, Mouseware makes independent computing accessible for people with upper-limb disabilities.

Our users include individuals with spinal cord injuries, muscular dystrophy, amputees, and other neurological conditions affecting hand mobility. For them, Mouseware is a gateway to education, job opportunities, digital skilling, and social connection. It has already transformed lives by enabling people to become artists, professionals, and creators in a digital world. At Dextroware Devices, our mission is to bridge the digital divide through inclusive technology.

Learn more at dextrowaredevices.com

dVerse Labs

CuriO, is a STEM learning ecosystem designed to enhance inclusive education and skilling for visually impaired (VI) students. It addresses two critical challenges: accessibility to STEM visuals and the scarcity of STEM-trained special education teachers.

The ecosystem consists of an AI powered tutoring app and two accessibility hardware add-ons. The tutor app delivers structured audio lessons from CBSE and State board syllabus. For the Indian market, the low cost CuriO Reader enables access to pre-deﬁned diagrams from school textbooks. For the US market, CuriO Refreshable, a high end tactile display, enables students to generate tactile graphics, from any visual content (textbooks, online libraries, web etc). As users interact with the tactile diagrams, they can listen to audio labels and descriptions.

Learn more at dVerse Labs

ARTSENS® : Next-Gen Vascular Health Assessment

Bringing next-generation vascular diagnostics to clinical practice—fast, accessible, and precise

ARTSENS® Plus is a non-invasive, operator-independent device designed to detect Early Vascular Ageing (EVA) —a critical indicator of cardiovascular risk. It is the only clinically validated device that measures carotid artery stiffness, aortic pulse wave velocity (PWV), and central blood pressur in a single, automated test, completed in just 10 minutes. Using real-time signal processing and AI-driven analysis, ARTSENS® Plus provides highly accurate, reproducible arterial health assessments with minimal user training. It is ideal for (a) Primary Screening – Early detection of vascular dysfunction to enable timely interventions, (b) Vascular Phenotyping – Identifying individuals who benefit from lifestyle vs. pharmacological management and (c) Risk Stratification – Predicting long-term cardiovascular risk based on vascular ageing.

Clinically Proven, Globally Recognized

Validated against FDA-approved predicates per international ARTERY society guidelines
Tested on 5000+ subjects , deployed in 10+ clinical research centers across India, Europe, and the USA
35+ patents, 100+ peer-reviewed publications
US FDA 510(k) under review, compliant with IEC 60601-1, -2, -37, EMI/EMC, and biocompatibility standards

Clinical Partners: Radboud UMC (Netherlands), AIIMS Delhi, JIPMER Pondicherry, CMC Vellore, Sitapati Hospital, SDM Dharwad, Kotakkal AVS

Industry Partner: VascRisk LLC

Learn more at artsens.tech

The ERA Device

Bringing endothelial health monitoring to the forefront of preventive cardiology!

The endothelium plays a critical role in regulating vascular tone and blood pressure. Its dysfunction is the earliest sign of vascular ageing, leading to stiff arteries, hypertension, and atherosclerosis. Yet, current assessments require specialized ultrasound equipment, skilled operators, and complex procedures—making routine screening impractical.

The ERA Device is a fully automated, non-invasive solution uses dual pulse sensors to measure brachial local PWV and continuously track vascular tone in response to reactive hyperemia—providing a reliable quantification of endothelial function. Designed in a wearable form factor, it also integrates ambulatory monitoring of blood pressure and vascular tone, making endothelial function assessment practical for routine clinical use.

A prototype has already been tested on 100 healthy volunteers, proving greater sensitivity and repeatability than conventional ultrasound-based FMD tests. Clinical validation is set for next year.

Clinical Partners: AIIMS Delhi, JIPMER Pondicherry

Non-contact Neonatal Health Monitoring (NNHM)

Transforming neonatal care—because the smallest patients deserve the biggest innovations!

Traditional neonatal monitoring relies on contact-based sensors like ECG electrodes and pulse oximeters, which pose risks such as skin irritation, motion artifacts, and infection exposure. Non-contact methods—computer vision, infrared thermography, and near-field sensing—offer a promising alternative but suffer from limited accuracy, motion sensitivity, and suboptimal spatiotemporal coverage in NICUs.

We are developing an AI-driven, multi-modal non-contact neonatal health monitoring system that integrates seamlessly into NICU radiant warmers. Our system utilizes:

Computer Vision & Deep Learning: AI-based object identification and neonatal skin segmentation ensure precise vitals extraction.
Infrared Thermography: Real-time, contact-free temperature tracking with high sensitivity.
Near-Field & Optical Sensing: Continuous respiratory rate and cardiac signal detection, mitigating motion-induced artifacts.
Sensor Fusion & AI Models: A robust algorithm pipeline combines multi-modal inputs to enhance reliability and accuracy.

Our AI models for neonatal motion detection, vitals tracking, and behavioral state identification have been successfully validated in initial trials on 40 neonates. Next steps involve clinical validation with advanced technology prototypes, ensuring scalability and real-world efficacy in neonatal intensive care.

Clinical Partner: Saveetha Medical College, Chennai

Department of Electrical Engineering,
Indian Institute of Technology Madras,
Chennai – 600036